Repeat Dose Study in Male Healthy Volunteer Smokers

Status:
Completed

Trial end date:
2008-07-24

Target enrollment:

Participant gender:

This is a 4 to 6 week study to look at the safety and PK profile of SB656933 in healthy male smokers

Phase 1

GlaxoSmithKline